MedElevator
Войти в исследования Neurology · 2021
Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI: The SMART-MR Study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rissanen Ina, Lucci Carlo, Ghaznawi Rashid, Hendrikse Jeroen, Kappelle L Jaap, Geerlings Mirjam I, UCC-SMART-Study Group
Аннотация
BACKGROUND AND OBJECTIVE: To investigate the association of silent vascular lesions, imaging negative ischemia, and symptomatic cerebrovascular disease with long-term progression of brain atrophy and cerebrovascular lesions in patients with arterial disease.
METHODS: Within the Second Manifestations of Arterial Disease-Magnetic Resonance (SMART-MR) study, stroke status of participants at baseline was classified as no cerebrovascular disease (reference group, n = 829), symptomatic cerebrovascular disease (n = 206), silent vascular lesion (n = 157), and imaging-negative ischemia (n = 90) according to clinical and MRI findings. With the use of linear mixed models, changes in brain and white matter hyperintensity (WMH) volumes at baseline and during 12 years of follow-up were studied in stroke classifications. Relative risks were estimated for new infarcts during follow-up associated with stroke classifications. Analyses were adjusted for age, sex, cardiovascular risk factors, and medications.
RESULTS: Symptomatic cerebrovascular disease associated with 0.35 SD (95% confidence interval [CI] 0.24-0.47) smaller brain volume and 0.61 SD (95% CI 0.48-0.74) larger WMH volume at baseline and increased risk for new infarcts during follow-up (risk ratio [RR] 2.89, 95% CI 2.00-4.16). Silent vascular lesions were associated with 0.15 SD (95% CI 0.01-0.88) smaller brain volume, 0.02 SD (95% CI 0.01-0.03) steeper brain atrophy slope, and 0.48 SD (95% CI 0.32-0.64) larger WMH volume at baseline, in addition to increased risk for lacunes (RR 2.08, 95% CI 1.48-2.94). Individuals with imaging-negative ischemia had increased risk for cortical infarcts (RR 2.88, 95% CI 2.17-3.82).
DISCUSSION: Patients with symptomatic cerebrovascular disease, silent vascular lesions, or imaging-negative ischemia have a different course of brain volume loss and cerebrovascular lesion development. These findings may have implications for future stroke risk and dementia and need further investigation.
METHODS: Within the Second Manifestations of Arterial Disease-Magnetic Resonance (SMART-MR) study, stroke status of participants at baseline was classified as no cerebrovascular disease (reference group, n = 829), symptomatic cerebrovascular disease (n = 206), silent vascular lesion (n = 157), and imaging-negative ischemia (n = 90) according to clinical and MRI findings. With the use of linear mixed models, changes in brain and white matter hyperintensity (WMH) volumes at baseline and during 12 years of follow-up were studied in stroke classifications. Relative risks were estimated for new infarcts during follow-up associated with stroke classifications. Analyses were adjusted for age, sex, cardiovascular risk factors, and medications.
RESULTS: Symptomatic cerebrovascular disease associated with 0.35 SD (95% confidence interval [CI] 0.24-0.47) smaller brain volume and 0.61 SD (95% CI 0.48-0.74) larger WMH volume at baseline and increased risk for new infarcts during follow-up (risk ratio [RR] 2.89, 95% CI 2.00-4.16). Silent vascular lesions were associated with 0.15 SD (95% CI 0.01-0.88) smaller brain volume, 0.02 SD (95% CI 0.01-0.03) steeper brain atrophy slope, and 0.48 SD (95% CI 0.32-0.64) larger WMH volume at baseline, in addition to increased risk for lacunes (RR 2.08, 95% CI 1.48-2.94). Individuals with imaging-negative ischemia had increased risk for cortical infarcts (RR 2.88, 95% CI 2.17-3.82).
DISCUSSION: Patients with symptomatic cerebrovascular disease, silent vascular lesions, or imaging-negative ischemia have a different course of brain volume loss and cerebrovascular lesion development. These findings may have implications for future stroke risk and dementia and need further investigation.